>
Date: Tue, 7 May 2002 16:31:20 -0700
See http://www.fool.com/news/take/2002/take020507.htm
Some excerpts:
With Novartis' move, a star in part leaves its birthplace for another
with greater opportunity than Europe's less-competitive and
less-lucrative drug market (that's not jingoism, but the focus of a
soon-to-be released European Commission report). And though Novartis
retains its newly expanded HQ operations in Basel, the move is not only
bad for Europe, but also highly symbolic for the Swiss. For years,
Swiss drug makers ruled the roost, dominated by famous but now absorbed
names like Ciba, Geigy, Hoffman, La Roche, and Sandoz (where LSD was
first synthesized). The powerful Swiss drug industry so influenced
politics and the economy that it could preserve its hegemony by
restricting the availability and price for natural remedies we take for
granted in the U.S.
Best regards
Michael
=================================================================
To unsubscribe from the swiss-list mailing list send the
message body of "unsubscribe swiss-list" to majordomo_at_swiss-list.com
or visit http://www.swiss-list.com/mailing/
Received on Wed May 08 2002 - 00:06:03 PDT
